The original COVID-19 boosters did a great job of preventing severe illness and hospitalization, even during the delta surge. Then came omicron and its subvariants, which are more transmissible than previous variants and ...
Oct 7, 2022
0
4
In a study of more than 80 men and women from Baltimore, Maryland, Johns Hopkins researchers have added to evidence that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly ...
Sep 29, 2022
0
22
Gum diseases are among the most common chronic human diseases, affecting between 20 to 50% of people worldwide. They happen when plaque, a sticky film of bacteria, builds up on teeth. The earliest stages of gum disease are ...
Sep 27, 2022
0
15
Results of a study led by VHIO investigators and published in Nature Medicine have unmasked mutations in the RNF43 gene as predictive biomarkers of response to treatment with anti-BRAF/EGFR combinatory therapy in patients ...
Sep 27, 2022
0
35
France became the latest country on Tuesday to authorize new COVID-19 vaccines that have been updated to target Omicron subvariants ahead of autumn booster campaign.
Sep 20, 2022
0
9
Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who ...
Sep 11, 2022
0
39
Negative symptoms such as reduced ability to experience of pleasure, lack of motivation and diminished ability to express emotional responses for relevant social interaction are strongly correlated with clinical and functional ...
Sep 9, 2022
0
12
Vaccinated people who were infected by the first omicron subvariants have four times greater protection than vaccinated people who were not infected. These results are part of a study that will be published today in the New ...
Sep 1, 2022
6
111
Pfizer Inc. said Monday that it has asked the U.S. Food and Drug Administration to approve the emergency use of an updated booster shot that targets several versions of the omicron variant.
Aug 23, 2022
0
5
Patients with metastatic non-small cell lung cancer who received a combined therapy of tremelimumab, durvalumab and chemotherapy experienced longer overall survival compared with those who received chemotherapy alone, regardless ...
Aug 9, 2022
0
2
